HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bilaj, F. Articles by Semelka, R. C. Search for Related Content PubMed PubMed Citation Articles by Bilaj, F. Articles by Semelka, R. C.

MR Imaging Findings in Autoimmune Hepatitis: Correlation with Clinical Staging¹

¹ From the Departments of Radiology (F.B., W.B.H., H.R., Z.F., R.C.S.), Medicine (R.S.), and Pathology and Laboratory Medicine (J.T.W.), University of North Carolina, CB 7510, 101 Manning Dr, Chapel Hill, NC 27599-7510; and Cardiovascular Disease Program, School of Public Health, University of North Carolina, Chapel Hill, NC (G.V.). Received July 19, 2005; revision requested September 6; revision received November 9; accepted December 23. Address correspondence to R.C.S. (e-mail: richsem{at}med.unc.edu).

PURPOSE: To retrospectively evaluate the morphologic and enhancement features of the liver on magnetic resonance (MR) images obtained in patients with autoimmune hepatitis (AIH) and to determine if there is a correlation between MR imaging findings and severity of clinical disease as measured with the Mayo end-stage liver disease (MELD) score.

MATERIALS AND METHODS: This study was compliant with the Health Insurance Portability and Accountability Act and approved by the institutional review board. The need for informed consent was waived. Thirty-two patients (29 female and three male patients; mean age, 44 years; age range, 14–69 years) undergoing treatment for AIH underwent unenhanced and gadolinium-enhanced MR imaging. Two radiologists reviewed all cases independently to determine the presence of patchy or heterogeneous liver enhancement, biliary duct changes, lymphadenopathy, and findings of portal hypertension. Fibrosis was graded as mild, moderate, or severe reticular (corresponding to a grading scale of 1–3) or as confluent. Agreement between radiologists was assessed by using coefficients. Mean MELD scores were compared across fibrosis categories by using the Kruskal-Wallis analysis of variance.

RESULTS: Of the 32 patients, two (6%) had no imaging findings of cirrhosis. Thirty patients (94%) had reticular fibrosis with a mean grade of 1.8. Six patients had confluent fibrosis, and all six had associated reticular fibrosis. Mild intrahepatic biliary duct dilatation involving the right and left lobes was observed in four patients (12%). Lymphadenopathy was observed in 12% of patients. None of the patients had hepatocellular carcinoma. There was no significant overall association between fibrosis grade and MELD score (P = .36).

CONCLUSION: Although fibrosis is a common feature in AIH and is often moderate to severe, no significant correlation between fibrosis grade and MELD score was found.

© RSNA, 2005

This article has been cited by other articles:

				J. Q. Knowlton, A. J. Taylor, M. Reichelderfer, and J. Stang Imaging of Biliary Tract Inflammation: An Update Am. J. Roentgenol., April 1, 2008; 190(4): 984 - 992. [Abstract] [Full Text] [PDF]